Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;6(3):e231455.
doi: 10.1001/jamanetworkopen.2023.1455.

Estimated Burden of Stroke in China in 2020

Affiliations

Estimated Burden of Stroke in China in 2020

Wen-Jun Tu et al. JAMA Netw Open. .

Abstract

Importance: Stroke is the leading cause of death in China. However, recent data about the up-to-date stroke burden in China are limited.

Objective: To investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations.

Design, setting, and participants: This cross-sectional study was based on a nationally representative survey that included 676 394 participants aged 40 years and older. It was conducted from July 2020 to December 2020 in 31 provinces in mainland China.

Main outcomes and measures: Primary outcome was self-reported stroke verified by trained neurologists during a face-to-face interviews using a standardized protocol. Stroke incidence were assessed by defining first-ever strokes that occurred during 1 year preceding the survey. Strokes causing death that occurred during the 1 year preceding the survey were considered as death cases.

Results: The study included 676 394 Chinese adults (395 122 [58.4%] females; mean [SD] age, 59.7 [11.0] years). In 2020, the weighted prevalence, incidence, and mortality rates of stroke in China were 2.6% (95% CI, 2.6%-2.6%), 505.2 (95% CI, 488.5-522.0) per 100 000 person-years, and 343.4 (95% CI, 329.6-357.2) per 100 000 person-years, respectively. It was estimated that among the Chinese population aged 40 years and older in 2020, there were 3.4 (95% CI, 3.3-3.6) million incident cases of stroke, 17.8 (95% CI, 17.5-18.0) million prevalent cases of stroke, and 2.3 (95% CI, 2.2-2.4) million deaths from stroke. Ischemic stroke constituted 15.5 (95% CI, 15.2-15.6) million (86.8%) of all incident strokes in 2020, while intracerebral hemorrhage constituted 2.1 (95% CI, 2.1-2.1) million (11.9%) and subarachnoid hemorrhage constituted 0.2 (95% CI, 0.2-0.2) million (1.3%). The prevalence of stroke was higher in urban than in rural areas (2.7% [95% CI, 2.6%-2.7%] vs 2.5% [95% CI, 2.5%-2.6%]; P = .02), but the incidence rate (485.5 [95% CI, 462.8-508.3] vs 520.8 [95% CI, 496.3-545.2] per 100 000 person-years; P < .001) and mortality rate (309.9 [95% CI, 291.7-328.1] vs 369.7 [95% CI, 349.1-390.3] per 100 000 person-years; P < .001) were lower in urban areas than in rural areas. In 2020, the leading risk factor for stroke was hypertension (OR, 3.20 [95% CI, 3.09-3.32]).

Conclusions and relevance: In a large, nationally representative sample of adults aged 40 years or older, the estimated prevalence, incidence, and mortality rate of stroke in China in 2020 were 2.6%, 505.2 per 100 000 person-years, and 343.4 per 100 000 person-years, respectively, indicating the need for an improved stroke prevention strategy in the general Chinese population.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Study Profile for China Stroke Prevention Project Committee Stroke Program in 2020
A stratified, cluster-randomized sampling design was used to select the screening points included in the study. Reasons for exclusion classified as "other" in the diagram included other reasons included household-level refusal, implicit refusal, and noncontact.
Figure 2.
Figure 2.. The Stroke Prevalence, Incidence, and Mortality Rate in China in 2020
A, The standardized rate of stroke prevalence in the 7 major geographic regions. B, The standardized rate of stroke incidence in the 7 major geographic regions. C, The standardized rate of stroke mortality in the 7 major geographic regions. Geographical regions of China included North China (Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia), Northeast China (Liaoning, Jilin, Heilongjiang), East China (Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, Shandong), South China (Guangdong, Guangxi, Hainan), Central China (Henan, Hubei, Hunan), Southwest China (Chongqing, Sichuan, Guizhou, Yunnan, Tibet), Northwest China (Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang). The small maps show the South China Sea Islands.
Figure 3.
Figure 3.. Multivariable Adjusted Odds Ratios for Stroke
aReference No. All models adjusted for age. Obesity was defined as body mass index (calculated as weight in kilograms divided by height in meters squared) greater than or equal to 28.0. Hyperhomocysteinemia was defined as serum homocysteine concentration greater than or equal to 15.0μmol/l. Please refer to the supplementary materials for the division of economic level of cities. Seven geographical regions of China included North China (Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia), Northeast China (Liaoning, Jilin, Heilongjiang), East China (Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, Shandong), South China (Guangdong, Guangxi, Hainan), Central China (Henan, Hubei, Hunan), Southwest China (Chongqing, Sichuan, Guizhou, Yunnan, Tibet), Northwest China (Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang).

Comment in

References

    1. GBD 2019 Diseases and Injuries Collaborators . Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-1222. doi:10.1016/S0140-6736(20)30925-9 - DOI - PMC - PubMed
    1. Li Z, Jiang Y, Li H, Xian Y, Wang Y. China’s response to the rising stroke burden. BMJ. 2019;364:l879. doi:10.1136/bmj.l879 - DOI - PMC - PubMed
    1. Wu S, Wu B, Liu M, et al. ; China Stroke Study Collaboration . Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394-405. doi:10.1016/S1474-4422(18)30500-3 - DOI - PubMed
    1. Feigin VL, Nguyen G, Cercy K, et al. ; GBD 2016 Lifetime Risk of Stroke Collaborators . Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429-2437. doi:10.1056/NEJMoa1804492 - DOI - PMC - PubMed
    1. Wang W, Jiang B, Sun H, et al. ; NESS-China Investigators . Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759-771. doi:10.1161/CIRCULATIONAHA.116.025250 - DOI - PubMed

Publication types